Table 3 Cox regression analyses with individual disease-related variables, controlled for gender and age at onset of psoriasis.
Disease-related variablesHypertensionMIFirst CVD event
HRp ValueHRp ValueHRp Value
Gender1.290.192.480.011.550.01
Age at onset of psoriasis1.010.081.000.741.000.73
Age at onset of PsA0.980.131.000.860.990.14
No of actively inflamed joints1.010.611.020.411.000.98
No of clinically deformed joints1.000.991.000.851.000.80
NSAIDs ever used1.570.302.530.371.270.50
Intra-articular steroid ever used1.200.341.240.561.230.23
DMARDs ever used1.210.310.860.641.110.51
Methotrexate ever used1.390.080.750.401.170.34
Biological agents ever used0.620.630.410.38
Steroids ever used1.370.151.480.291.300.18
Immunosuppressive drugs ever used1.310.140.790.471.150.40
Diabetes3.40<0.011.790.362.490.01
Daily alcohol use1.550.380.880.911.620.31
Current smoker0.460.2915.890.011.030.96
Logarithm of uric acid1.470.152.480.091.490.08
Logarithm of triglycerides1.44<0.011.520.031.47<0.01
Logarithm of cholesterol1.260.221.400.251.310.10
ESR1.001.001.010.341.000.69
Interaction of ESR and gender1.010.141.010.581.010.15
PASI score (base category = 0)0.020.19<0.01
    0<PASI⩽100.850.671.840.560.910.79
    10<PASI⩽200.720.511.230.870.680.42
    PASI >202.270.085.590.132.700.02
  • CVD, cardiovascular disease; DMARDs, disease-modifying antirheumatic drugs; ESR, erythrocyte sedimentation rate; HR, hazard ratio; MI, myocardial infarction; NSAIDs, non-steroidal anti-inflammatory drugs; PsA, psoriatic arthritis; PASI, Psoriasis Area and Severity Index.